TriSalus Life Sciences, Inc. (TLSI) vs Treace Medical Concepts, Inc. (TMCI)

A side-by-side comparison of TriSalus Life Sciences, Inc. and Treace Medical Concepts, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — TLSI vs TMCI

growth of $100 · dividends reinvested · last 5y
TLSI -55.2% (-14.8%/yr)TMCI -82.5% (-29.4%/yr)TLSI compounded faster over this window
050100150Start $10020222023202420252026$45$18
TLSI TMCI

TLSI vs TMCI: by the numbers

  • •TLSI is the larger company ($263M vs $259M market cap).
  • •Both run net losses; TMCI's is the smaller (-28.99% vs -62.59% net margin).

Metrics side by side

Valuation

MetricTLSITMCI
P/S ratio5.831.26
P/B ratio40.143.83

Profitability

MetricTLSITMCI
Gross margin85.79%79.45%
Operating margin-59.68%-26.17%
Net margin-62.59%-28.99%
ROE-430.72%-87.86%
ROIC-59.50%-37.64%

Growth (annualized)

MetricTLSITMCI
Revenue CAGR (5Y)N/A21.44%
Total return CAGR (5Y)-15.05%-29.41%

Frequently asked

How have TLSI and TMCI total returns compared?
Over the past 5 years, TLSI delivered -15.05% and TMCI delivered -29.41% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.